Table 1.
Name | Gene | Effect on MC synthesis | Effect on GC synthesis | Effect on sex steroid synthesis | Key analytic steroid abnormalities | Other |
---|---|---|---|---|---|---|
Congenital lipoid adrenal hyperplasia | StAR |
Classic: hyperreninemic, hypokalaemic hypotension/neonatal salt-wasting crisis Nonclassic: variable degrees/normal |
Classic: neonatal adrenal insufficiency Non-classic: late-onset adrenal insufficiency |
Classic: female external genitalia in 46,XY; spontaneous ovarian sex steroid production in 46,XX reported Nonclassic: variable degrees of 46,XY DSD |
Absence/reduction of all steroid classes, including precursors | Large adrenals with accumulating cholesterol and cholesterol metabolites Also affects gonadal androgen production |
P450 side-chain cleavage deficiency | CYP11A1 | As above | As above | As above | As above | Small, hypoplastic adrenals Also affects gonadal androgen production |
CAH due to 21-hydroxylase deficiency | CYP21A2 |
Classic: hyperreninemic, hypokalaemic hypotension/neonatal salt-wasting crisis Nonclassic: variable degrees/normal |
Classic: neonatal adrenal insufficiency Nonclassic: various degrees of (partial) adrenal insufficiency; normal |
Classic: prenatal androgen excess (46,XX DSD); maybe the only symptom from birth (“simple virilizers”) Nonclassic: various degrees of adrenal androgen excess after birth |
Serum: elevated 17OHP and 21-deoxycortisol Urine: elevated metabolites of 17OHP (17OH-pregnanolone [17HP], pregnanetriolone [PT]) and 21-deoxycortisol (pregnanetriolone [P'TONE]) |
Enlarged adrenals |
CAH due to 11-hydroxylase deficiency | CYP11B1 |
Classic: low renin hypertension with normal aldosterone levels Nonclassic: mild/absent hypertension |
Classic: adrenal insufficiency Nonclassic: various degrees of partial adrenal insufficiency; normal |
Classic: prenatal androgen excess (46,XX DSD) Nonclassic: various degrees of androgen excess after birth |
Serum: elevated 11-deoxycortisol [S] and 11-deoxycorticosterone [DOC] Urine: elevated metabolites of S (tetrahydro-11-deoxycortisol [THS]) and DOC (tetrahydrocorticosterone [THDOC]) |
|
CAH due to 17-hydroxylase deficiency | CYP17A1 | Low-renin, hypokalaemic hypertension; can be absent in partial defects | Various degrees of adrenal insufficiency, often rarely adrenal crisis (cross-reactivity of MC precursors on GC receptor) | 46,XY DSD from birth; absence of secondary sexual characteristics in both sexes |
Serum: elevated corticosterone [B] and 11-deoxycorticosterone [DOC]; low androgens Urine: increased ratio of MC over GC metabolites to assess 17-hydroxylase activity; increased ratio of androgens over GC metabolites to assess 17,20 lyase activity |
Also affects gonadal androgen production |
CAH due to 3ß-hydroxysteroid-dehydrogenase deficiency | HSD3B2 |
Classic: hyperreninemic, hypokalaemic hypotension/neonatal salt-wasting crisis Nonclassic: variable degrees/normal |
Classic: neonatal adrenal insufficiency Nonclassic: various degrees of (partial) adrenal insufficiency; normal |
Classic: DSD in both sexes Nonclassic: premature adrenarche, precocious pseudopuberty, irregular menstrual cycles |
Serum: increased (stimulated) ratio of Δ4 (progesterone, 17OHP, androstenedione) over 5 steroids (pregnenolone, 17Preg, DHEA) Urine: elevated ratio of DHEA over GC metabolites and 5-pregnenetriol (5PT) over GC metabolites |
Also affects gonadal androgen production |
CAH due to P450 oxidoreductase deficiency | POR | Some elevation of MC metabolites but overt arterial hypertension has not been reported | Various degrees of GC deficiency in 85% of patients | DSD in both sexes from birth in 75% of patients; delayed puberty in both sexes of various degrees |
Serum: unspecific mild elevation of 17OHP; increased pregnenolone, progesterone, 17OHP Urine: combined impairment of diagnostic ratios for CYP17A1 and CYP21A2; distinct accumulation of pregnenolone metabolites (pregnanediol [PD]) |
Also affects gonadal androgen production; affects bone development: skeletal malformations of the Antley-Bixler phenotype spectrum |
Cytochrome b5 deficiency | CYB5A | None | None | 46,XY DSD; absence of puberty in 46,XX |
Serum: isolated sex steroid deficiency Urine: normal ratio of MC over GC metabolites reflecting normal 17-hydroxylase activity; increased ratio of androgen over GC metabolites reflective of 17,20 lyase activity |
Raised methaemoglobin levels; also affects gonadal androgen production |
Apparent DHEA sulfotransferase deficiency | PAPSS2 | None | None | Premature adrenarche and polycystic ovary syndrome (hyperandrogenemic oligoanovulation) |
Serum: very low/undetectable DHEAS and sulfated steroid compounds, with high DHEA and downstream androgens (testosterone, androstenedione) Urine: high androgen metabolites and precursors |
Also causes skeletal abnormalities: brachyolmia type 4 |
MC, mineralocorticoid; GC, glucocorticoid; CAH, congenital adrenal hyperplasia; DSD, disorders of sex development.